On January 3, 2023 Valo Health, Inc. ("Valo"), the technology company using human-centric data and artificial intelligence (AI) powered computation to transform the drug discovery and development process, reported that it will participate in the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, January 9th – 12th (Press release, Valo Health, JAN 3, 2023, View Source [SID1234625761]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

David Berry, M.D. PhD, Valo’s CEO and founder, is scheduled to present on Tuesday, January 10, 2023 at 2:30 PM PT (5:30 PM ET) in the Golden Gate Room (31st Fl) at the Westin St. Francis in San Francisco.

Valo’s management, investor relations and business development leadership will be attending and available throughout the conference for meetings.